Skip to main content
. 2019 Dec 23;11(3):573–584. doi: 10.1007/s13300-019-00732-w

Fig. 4.

Fig. 4

Difference in glycated haemoglobin with rapid-acting insulin analogues and regular human insulin. a Change from baseline in glycated haemoglobin (%) in patients with type 1 diabetes (random-effects model); and b change from baseline in glycated haemoglobin (%) in patients with type 2 diabetes (fixed-effects model). CI confidence interval, MD mean difference, RAIA rapid-acting insulin analogues, RHI regular human insulin